An exploratory mixed method study on the follow up status and quality of life among recurrent tuberculosis patients in South India.


Journal

The Indian journal of tuberculosis
ISSN: 0019-5707
Titre abrégé: Indian J Tuberc
Pays: India
ID NLM: 0373027

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 02 06 2020
accepted: 24 07 2020
entrez: 20 10 2020
pubmed: 21 10 2020
medline: 14 8 2021
Statut: ppublish

Résumé

After completion of treatment of Tuberculosis (TB), many patients can have long-term physical sequelae, which in some cases results in life-long impairment and further stigma. To determine the follow up status and quality of life of post-treatment among Category 2 TB patients under RNTCP and to explore the factors affecting the Quality of Life. The present study was done in urban area of Villupuram district of Tamil Nadu using Exploratory mixed methods study design. In the first phase case-control study was conducted with 100 post treatment category 2 TB patients (cases) and 100 non-TB patients (controls) matched for age and gender. The quality of life of the respondents was assessed by (WHOQOL-BREF) questionnaire (Quantitative), followed by five in-depth interviews among cases with extreme scores (Qualitative). The mean scores of "perceived physical health" and "perceived psychological health" among cases after completion of treatment was significantly lower than the mean scores in controls. The determinants for perceived physical health were age, years of education and marital status. The determinants for psychological health were age, marital status and associated comorbidities. In-depth interview explored that major perspectives of cases affecting quality of life were side effects of drugs, loss of social support, loss of employment and psychological factors like anxiety, depression. HR-QOL among post treatment TB patients was reduced. Efforts should be made to counsel TB patients, family members, relatives and their workplace regarding their care, support and challenges to have a reasonable QOL.

Identifiants

pubmed: 33077053
pii: S0019-5707(20)30099-8
doi: 10.1016/j.ijtb.2020.07.028
pii:
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-522

Informations de copyright

Copyright © 2020 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have none to declare.

Auteurs

M Rajalakshmi (M)

Department of Community Medicine, Sri Manakula Vinayagar Medical College and Hospital, Pondicherry, India. Electronic address: drrajalakshmimahe@gmail.com.

G Kalaiselvan (G)

Department of Community Medicine, Sri Manakula Vinayagar Medical College and Hospital, Pondicherry, India.

R Sudhakar (R)

District Tuberculosis Office, Villupuram, India.

P T Dhikale (PT)

Department of Community Medicine, Hindu Hruday Samrat Balasaheb Thackarey Medical College (HBTMC) and Dr Rustom Narsi Cooper Municipal General Hospital, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH